PEAK6 Investments’s Exelixis EXEL Stock Holding History

PEAK6 Investments’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,000	Closed	-$500K	–	3847
2019 Q1	$500K	Buy	+21,000	New	+$479K	﹤0.01%	2376

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

PEAK6 Investments's EXEL Position: Q1 2021 in Review

PEAK6 Investments sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 905 shares — an estimated $18K sold.

PEAK6 Investments first reported a position in EXEL in Q2 2019 and held it in 7 quarters. The position peaked at $411K in Q3 2019. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

PEAK6 Investments reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
PEAK6 Investments sold 905 Exelixis shares in Q1 2021, an estimated $18K.
PEAK6 Investments first reported a position in Exelixis in Q2 2019 and held it in 7 quarters.
PEAK6 Investments's Exelixis position peaked at $411K in Q3 2019.
347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on PEAK6 Investments's 13F filing for Q1 2021, filed 14 May 2021.